Parkinson's drug wards off blindness in oldies

Published On 2015-11-15 10:55 GMT   |   Update On 2015-11-15 10:55 GMT
Washington D.C, Nov 15 (ANI): A team of researchers have discovered a drug, which is normally used to treat Parkinson's disease, that may be able to delay or prevent a common form of blindness among older people.

Researchers discovered a biological connection between darker pigmented eyes, which are known to be resistant to Age-related macular degeneration (AMD), and increased levels of a chemical called L-DOPA in those eyes. L-DOPA is frequently prescribed for Parkinson's patients.

They reported that patients receiving L-DOPA were significantly less likely to get AMD, and when they did, its onset was significantly delayed.

Senior author Brian McKay of the University of Arizona said that rather than looking at what might cause AMD, they instead wondered why certain people were protected from AMD.

BrightFocus president Stacy Pagos Haller said that this exciting breakthrough showed the power of scientific discovery to give hope to millions of people across the nation and the world.

The study is published in the American Journal of Medicine. (ANI)
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News